EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, JMS Co's Enterprise Value is 円28,687 Mil.
JMS Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was 円613 Mil. Therefore, JMS Co's EV-to-EBIT for today is 46.80.
The historical rank and industry rank for JMS Co's EV-to-EBIT or its related term are showing as below:
TSE:7702'
s EV-to-EBIT Range Over the Past 10 Years
Min: 8.62 Med: 22.1 Max: 54.86
Current: 46.8
During the past 13 years, the highest EV-to-EBIT of JMS Co was 54.86. The lowest was 8.62. And the median was 22.10.
TSE:7702's EV-to-EBIT is ranked worse than 83.07% of 449
companies
in the Medical Devices & Instruments industry
Industry Median: 19.58
vs TSE:7702: 46.80
The historical data trend for JMS Co's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, JMS Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JMS Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JMS Co's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where JMS Co's EV-to-EBIT falls into.
JMS Co's current Enterprise Value is 円28,687 Mil.
JMS Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円613 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JMS Co (TSE:7702) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
JMS Co's Enterprise Value for the quarter that ended in Dec. 2023 was 円28,222 Mil.
JMS Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円613 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JMS Co EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of JMS Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
JMS Co Ltd is a Japan-based medical equipment manufacturer. The company is primarily engaged in the manufacture, sale, export, and import of medical equipment and pharmaceuticals. Products offered by the company include an infusion pump, syringe pump, surgical gown, peritoneal dialysate, dialyzer, mask cap, sheet for treatment, pacemaker, heat exchanger, blood bag, among others. JMS has network operations in various countries including Europe, North America, Asia, the Middle East, Latin America and Africa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:7702 has been successfully added to your 